Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record provides details of Sanofi’s completed Phase 3 study evaluating dupilumab versus placebo for prurigo nodularis, including its study plan, participant criteria, and outcome measures. It also includes study documents, publications, and record history.
    Difference
    92%
    Check dated 2026-11-11T01:59:52.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:32:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    An NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:30:58.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The site's displayed revision identifier changes from v3.7.0 to v3.7.1 while the study page remains inaccessible with a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:35:37.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study details and navigation. This prevents access to the study record and its associated information.
    Difference
    20%
    Check dated 2026-09-23T00:42:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, reflecting a software update to the ClinicalTrials.gov page. This change does not alter the study details, eligibility criteria, or results presented on the page.
    Difference
    0.0%
    Check dated 2026-09-15T23:55:10.000Z thumbnail image

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.